Source: International Congress 2017 – ILDs: clinical problems
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
d. eid (Egypt, Egypt). Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases. 861

Member's Comments

No comment yet.

Related content which might interest you: Determination of pulmonary hypertension degree in patients with interstitial lung diseases Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015 Biomarkers for pulmonary hypertension in interstitial lung disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Post-bronchodilator FVC determines pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017 Year: 2018 Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019